NEW HAVEN, Conn., Oct. 14, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in ...
Mutational spectrum of cell proliferation genes as early predictive markers for aggressive disease in endometrial cancers. Studies in the neoadjuvant setting. Study Number of Patients (n) Outcome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback